| Dr James Michael Herrold, MD | |
|
3875 E Overland Rd, Suite 201, Meridian, ID 83642-9005 | |
| (208) 343-6200 | |
| (208) 344-8355 |
| Full Name | Dr James Michael Herrold |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 35 Years |
| Location | 3875 E Overland Rd, Meridian, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235166885 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | M7321 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Les Bois Neurology Chartered | 6901993088 | 2 |
| Saint Alphonsus Regional Medical Center Inc | 3476462359 | 509 |
News Archive
Scientists on the Norwich Research Park have sequenced the genome of a novel strain of Clostridium botulinum, one of the most dangerous pathogens known to man. The strain produces an unusual botulinum neurotoxin, known as type A5 neurotoxin, which was isolated by the Health Protection Agency, following a case of wound botulism.
By testing formerly blind patients within weeks of sight restoration, Sinha and his colleagues found that subjects had very limited ability to distinguish an object from its background, identify overlapping objects, or even piece together the different parts of an object. The patients gradually improved over time, and the new study suggests that dynamic information - that is, input from moving objects - is critical to the brain's ability to learn to segregate objects from their backgrounds (a task known as visual integration).
Endo Pharmaceuticals (NASDAQ:ENDP) and Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) announced today that they have entered into a merger agreement under which Endo will commence a tender offer to acquire 100 percent of the outstanding shares of Indevus for approximately $370 million, or $4.50 per Indevus share, in cash, and up to an additional approximately $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones.
Researchers from UT Southwestern's Charles and Jane Pak Center for Mineral Metabolism and Clinical Research and Internal Medicine's Division of Nephrology recently published work in Nature that reveals the molecular structure of the so-called "anti-aging" protein alpha Klotho (a-Klotho) and how it transmits a hormonal signal that controls a variety of biologic processes.
› Verified 4 days ago
| Entity Name | Saint Alphonsus Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649357716 PECOS PAC ID: 3476462359 Enrollment ID: O20040204001036 |
News Archive
Scientists on the Norwich Research Park have sequenced the genome of a novel strain of Clostridium botulinum, one of the most dangerous pathogens known to man. The strain produces an unusual botulinum neurotoxin, known as type A5 neurotoxin, which was isolated by the Health Protection Agency, following a case of wound botulism.
By testing formerly blind patients within weeks of sight restoration, Sinha and his colleagues found that subjects had very limited ability to distinguish an object from its background, identify overlapping objects, or even piece together the different parts of an object. The patients gradually improved over time, and the new study suggests that dynamic information - that is, input from moving objects - is critical to the brain's ability to learn to segregate objects from their backgrounds (a task known as visual integration).
Endo Pharmaceuticals (NASDAQ:ENDP) and Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) announced today that they have entered into a merger agreement under which Endo will commence a tender offer to acquire 100 percent of the outstanding shares of Indevus for approximately $370 million, or $4.50 per Indevus share, in cash, and up to an additional approximately $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones.
Researchers from UT Southwestern's Charles and Jane Pak Center for Mineral Metabolism and Clinical Research and Internal Medicine's Division of Nephrology recently published work in Nature that reveals the molecular structure of the so-called "anti-aging" protein alpha Klotho (a-Klotho) and how it transmits a hormonal signal that controls a variety of biologic processes.
› Verified 4 days ago
| Entity Name | Les Bois Neurology Chartered |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275721912 PECOS PAC ID: 6901993088 Enrollment ID: O20071106000762 |
News Archive
Scientists on the Norwich Research Park have sequenced the genome of a novel strain of Clostridium botulinum, one of the most dangerous pathogens known to man. The strain produces an unusual botulinum neurotoxin, known as type A5 neurotoxin, which was isolated by the Health Protection Agency, following a case of wound botulism.
By testing formerly blind patients within weeks of sight restoration, Sinha and his colleagues found that subjects had very limited ability to distinguish an object from its background, identify overlapping objects, or even piece together the different parts of an object. The patients gradually improved over time, and the new study suggests that dynamic information - that is, input from moving objects - is critical to the brain's ability to learn to segregate objects from their backgrounds (a task known as visual integration).
Endo Pharmaceuticals (NASDAQ:ENDP) and Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) announced today that they have entered into a merger agreement under which Endo will commence a tender offer to acquire 100 percent of the outstanding shares of Indevus for approximately $370 million, or $4.50 per Indevus share, in cash, and up to an additional approximately $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones.
Researchers from UT Southwestern's Charles and Jane Pak Center for Mineral Metabolism and Clinical Research and Internal Medicine's Division of Nephrology recently published work in Nature that reveals the molecular structure of the so-called "anti-aging" protein alpha Klotho (a-Klotho) and how it transmits a hormonal signal that controls a variety of biologic processes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Michael Herrold, MD 2499 N Corsey Way, Eagle, ID 83616 Ph: (208) 440-6345 | Dr James Michael Herrold, MD 3875 E Overland Rd, Suite 201, Meridian, ID 83642-9005 Ph: (208) 343-6200 |
News Archive
Scientists on the Norwich Research Park have sequenced the genome of a novel strain of Clostridium botulinum, one of the most dangerous pathogens known to man. The strain produces an unusual botulinum neurotoxin, known as type A5 neurotoxin, which was isolated by the Health Protection Agency, following a case of wound botulism.
By testing formerly blind patients within weeks of sight restoration, Sinha and his colleagues found that subjects had very limited ability to distinguish an object from its background, identify overlapping objects, or even piece together the different parts of an object. The patients gradually improved over time, and the new study suggests that dynamic information - that is, input from moving objects - is critical to the brain's ability to learn to segregate objects from their backgrounds (a task known as visual integration).
Endo Pharmaceuticals (NASDAQ:ENDP) and Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) announced today that they have entered into a merger agreement under which Endo will commence a tender offer to acquire 100 percent of the outstanding shares of Indevus for approximately $370 million, or $4.50 per Indevus share, in cash, and up to an additional approximately $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones.
Researchers from UT Southwestern's Charles and Jane Pak Center for Mineral Metabolism and Clinical Research and Internal Medicine's Division of Nephrology recently published work in Nature that reveals the molecular structure of the so-called "anti-aging" protein alpha Klotho (a-Klotho) and how it transmits a hormonal signal that controls a variety of biologic processes.
› Verified 4 days ago
Martha A Cline, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3875 E Overland Road, Meridian, ID 83642 Phone: 208-343-3976 Fax: 208-333-9942 | |
Mary Hannah Rankin, FNP Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1672 S Woodsage Ave Ste 120, Meridian, ID 83642 Phone: 208-515-2273 | |
Megan M Conover, PAC Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2321 E Gala St Ste 3, Meridian, ID 83642 Phone: 208-888-5848 Fax: 208-888-0884 | |
Dr. Scott Partridge Hoopes, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2273 E Gala St, Suite 100, Meridian, ID 83642 Phone: 208-898-8899 | |
Huiyong Chong Goodyear-fassihi, PMHNP-BC Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1545 E Leighfield Dr Ste 100, Meridian, ID 83646 Phone: 208-957-6871 | |
Dr. Anna I Irwin, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 520 S Eagle Rd, St. Luke's Clinic-neurology, Meridian, ID 83642 Phone: 208-706-3600 |